Anna Majer
Impact in
-
- MicroRNA in disease regulation
- Infectious Diseases top 10%
- Viral Infections and Vectors
Papers in
-
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 3
-
- Prion Diseases and Protein Misfolding 8
- Co-authors
- Stephanie A. Booth (17 shared papers)Georg Hausner (4 shared papers)Sarah J. Medina (6 shared papers)Timothy F. Booth (4 shared papers)Yulian Niu (4 shared papers)Kathy L. Frost (4 shared papers)Amrit S. Boese (5 shared papers)Reuben Saba (3 shared papers)
- Journals
- Scientific Reports (2 papers)Viruses (2 papers)Expert Opinion on Drug Discovery (1 paper)DNA and Cell Biology (1 paper)Brain Research (1 paper)
- Partner nations
- CanadaUnited StatesFrance
In The Last Decade
Anna Majer
28 papers receiving 642 citations
Peers
Comparison fields: 5 of 71
- Cancer Research 121
- Infectious Diseases 144
- Neurology 62
- Molecular Biology 356
- Public Health, Environmental and Occupational Health 133
Countries citing papers authored by Anna Majer
This map shows the geographic impact of Anna Majer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Majer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Majer more than expected).
Fields of papers citing papers by Anna Majer
This network shows the impact of papers produced by Anna Majer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Majer. The network helps show where Anna Majer may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Majer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 90 | |
| 2 | 2012 | 85 | |
| 3 | 2017 | 83 | |
| 4 | 2009 | 62 | |
| 5 | 2017 | 56 | |
| 6 | 2009 | 42 | |
| 7 | 2020 | 34 | |
| 8 | 2017 | 32 | |
| 9 | 2017 | 26 | |
| 10 | 2013 | 25 | |
| 11 | 2019 | 22 | |
| 12 | 2020 | 18 | |
| 13 | 2016 | 14 | |
| 14 | 2007 | 12 | |
| 15 | 2010 | 8 | |
| 16 | 2013 | 7 | |
| 17 | 2014 | 5 | |
| 18 | 2021 | 4 | |
| 19 | 2014 | 4 | |
| 20 | 2011 | 4 |
About Anna Majer
Anna Majer is a scholar working on Cancer Research, Molecular Biology, Infectious Diseases, Developmental Neuroscience and Neurology, having authored 29 papers that have together received 653 indexed citations. Recurring topics across this work include Prion Diseases and Protein Misfolding (8 papers), MicroRNA in disease regulation (8 papers), Viral gastroenteritis research and epidemiology (3 papers), Cancer-related molecular mechanisms research (3 papers), Viral Infections and Immunology Research (3 papers), Mosquito-borne diseases and control (3 papers), Neurogenesis and neuroplasticity mechanisms (3 papers) and Respiratory viral infections research (2 papers). The work is most often cited by research in Cancer Research (121 citations), Infectious Diseases (144 citations), Neurology (62 citations), Molecular Biology (356 citations) and Public Health, Environmental and Occupational Health (133 citations). Anna Majer has collaborated with scholars based in Canada, United States and France. Frequent co-authors include Stephanie A. Booth, Georg Hausner, Sarah J. Medina, Timothy F. Booth, Yulian Niu, Kathy L. Frost, Amrit S. Boese, Reuben Saba, Kathy Manguiat and David R. Edgell. Their work appears in journals such as Scientific Reports, Viruses, Expert Opinion on Drug Discovery, DNA and Cell Biology and Brain Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.